By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

NexGenix Pharmaceuticals Holdings, Inc. 

Headquarters:
152 West 57th Street, Suite 11B
New York, New York 10019 U.S.A.

Phone: 212-974-3006 Fax: 212-974-1042

Laboratory:
849 Mitten Road, Suite 104

Burlingame  California  94010  U.S.A.
Phone: 650-697-8500 Fax: 650-697-8530


SEARCH JOBS


Industry
Pharmaceutical






Company News
Provence Technologies and NexGenix Pharmaceuticals Holdings, Inc. Announce Successful Lead Compound Development 6/27/2011 12:34:34 PM
NexGenix Pharmaceuticals Holdings, Inc. Release: US Patent Granted for a New Family of Heat Shock Protein 90 (Hsp90) Inhibitors for the Treatment of Cancer and Neurodegenerative Indications 5/20/2011 7:08:27 AM
NexGenix Pharmaceuticals Holdings, Inc. Awarded Phase I Grant from the National Institute of Neurological Disorders and Stroke 10/22/2009 11:08:36 AM
NexGenix Pharmaceuticals Holdings, Inc. Presents Data on a Novel Small Molecule Inhibitor of Heat Shock Protein 90 (Hsp90) 4/17/2008 7:54:35 AM
NexGenix Pharmaceuticals Holdings, Inc. Presents Data on a Novel Small Molecule Inhibitor of Heat Shock Protein 90 (Hsp90) at the GTCbio Cancer Drugs Research & Development Conference 2/25/2008 6:44:35 AM
NexGenix Pharmaceuticals Holdings, Inc. Enters into Exclusive World-wide License to Develop Novel Hsp90 Inhibitors 9/26/2007 10:16:14 AM
NexGenix Pharmaceuticals Holdings, Inc. Closes $3.9M Round of Financing 7/13/2007 9:19:36 AM
NexGenix Pharmaceuticals, LLC To Present At Rodman & Renshaw 8th Annual Healthcare Conference 10/24/2006 12:04:05 PM
NexGenix Pharmaceuticals, LLC Announces Key Personnel Appointments As It Prepares To Enter Clinical Trials In The US 9/25/2006 1:19:21 PM
NexGenix Pharmaceuticals, LLC To Present At Biotechnology Industry Organization (BIO) VentureForum East 2006 5/23/2006 10:54:09 AM
//-->